From MHRA registration and in-licensing to NHS distribution and commercial partnering — we offer a clearly defined service model for each stage of the journey.
We secure distribution rights and in-licensing agreements for products already registered in the UK, or European products seeking a UK commercial launch. Our established GDP-compliant distribution model means we can move quickly from agreement to market.
We manage the full lifecycle of UK marketing authorisation — from independent national route applications to Certificate of Authorisation (COA) transfers and MA acquisitions from existing UK licence holders.
We work with established brands to identify and unlock new value — refreshing commercial strategies, identifying new channels, and delivering on NHS opportunities that others overlook. Ideal for licence holders who need a UK commercial engine without building one from scratch.
Drawing on our European manufacturing network and the Unifarma Group's relationships with 40+ EU GMP-approved manufacturers, we bring niche generics — particularly injectables, RTU formulations, and specialist oral products — into the UK market with end-to-end commercial management.
Tell us about your product or situation and we will identify the best route forward together.